Hemodialysis International | October 1, 2020
Use of a gentamicin‐citrate lock leads to lower catheter‐related bloodstream infection rates and reduced cost of care in hemodialysis patients
Authors: Wael F. Hussein, Norma Gomez, Sumi J. Sun, Junhua Yu, Fang Yang, Michael Ajuria, Graham E. Abra, & Brigitte Schiller
View full publication
Central venous catheters (CVC) are a major contributor to infections in hemodialysis (HD) patients, leading to high morbidity and mortality. Gentamicin‐citrate (GC) lock is used as standard of care at centers belonging to a mid‐size dialysis organization. Four outpatient HD centers acquired by the organization continued to use heparin for catheter locks for a period of time before converting to the provider's standard of using GC lock.
